Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 30;10(11):e0143084.
doi: 10.1371/journal.pone.0143084. eCollection 2015.

Diabetes Prevalence in Sweden at Present and Projections for Year 2050

Affiliations

Diabetes Prevalence in Sweden at Present and Projections for Year 2050

Tomas Andersson et al. PLoS One. .

Abstract

Background: Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors.

Method: To project the future burden of diabetes we used information on the prevalence of diabetes from the national drug prescription registry (adults ≥ 20 years), previously published data on relative mortality in people with diabetes, and population demographics and projections from Statistics Sweden. Alternative scenarios were created based on different assumptions regarding the future incidence of diabetes.

Results: Between 2007 and 2013 the prevalence of diabetes rose from 5.8 to 6.8% in Sweden but incidence remained constant at 4.4 per 1000 (2013). With constant incidence and continued improvement in relative survival, prevalence will increase to 10.4% by year 2050 and the number of afflicted individuals will increase to 940 000. Of this rise, 30% is accounted for by changes in the age structure of the population and 14% by improved relative survival in people with diabetes. A hypothesized 1% annual rise in incidence will result in a prevalence of 12.6% and 1 136 000 cases. Even with decreasing incidence at 1% per year, prevalence of diabetes will continue to increase.

Conclusion: We can expect diabetes prevalence to rise substantially in Sweden over the next 35 years as a result of demographic changes and improved survival among people with diabetes. A dramatic reduction in incidence is required to prevent this development.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Prevalence of diabetes in Sweden 2007–2013 and projections for 2014–2050.
Fig 2
Fig 2. Prevalence of diabetes in Sweden 2007–2013 and projections for 2014–2050, by sex.
Fig 3
Fig 3. Number of patients with diabetes in Sweden 2007–2013 and projections for 2014–2050.

References

    1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49. 10.1016/j.diabres.2013.11.002 - DOI - PubMed
    1. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012;35:1252–7. 10.2337/dc11-1162 - DOI - PMC - PubMed
    1. Nwaneri C, Bowen-Jones D, Cooper H, Chikkaveerappa K, Afolabi BA. Falling mortality rates in Type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study. Postgrad Med J. 2012;88:679–83 10.1136/postgradmedj-2012-130877 - DOI - PubMed
    1. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K; Steering Group of the National Diabetes Register. The Danish National Diabetes Register: trends in incidence. prevalence and mortality. Diabetologia. 2008;51:2187–96. 10.1007/s00125-008-1156-z - DOI - PubMed
    1. Eliasson M, Talbäck M, Rosén M. Improved survival in both men and women with diabetes between 1980 and 2004—a cohort study in Sweden. Cardiovasc Diabetol 2008;7:32 10.1186/1475-2840-7-32 - DOI - PMC - PubMed